The impact of inflammatory markers on prognosis of stage II colon cancers depends on tumour sidedness.

Jui-Shen Chang,Hou-Hsuan Cheng,Sheng-Chieh Huang,Hung-Hsin Lin,Shih-Ching Chang,Chun-Chi Lin

ANZ journal of surgery（2023）

引用 0|浏览7

暂无评分

摘要

The profiles and prognostic impact of inflammatory markers are significantly different between stage II RCC and LCC patients. Researchers should take sidedness into consideration when addressing survival analysis of inflammatory markers.

查看译文

关键词

colon cancer,inflammatory markers,sidedness

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要